Related Experiment Video
Updated: Jul 26, 2026
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia
A Mupo1, M Seiler2, V Sathiaseelan3
1Haematological Cancer Genetics, Wellcome Sanger Institute, Hinxton, Cambridge, UK.
Abstract:
Heterozygous somatic mutations affecting the spliceosome gene SF3B1 drive age-related clonal hematopoiesis, myelodysplastic syndromes (MDS) and other neoplasms. To study their role in such disorders, we generated knock-in mice with hematopoietic-specific expression of Sf3b1-K700E, the commonest type of SF3B1 mutation in MDS. Sf3b1K700E/+ animals had impaired erythropoiesis and progressive anemia without ringed sideroblasts, as well as reduced hematopoietic stem cell numbers and host-repopulating fitness. To understand the molecular basis of these observations, we analyzed global RNA splicing in Sf3b1K700E/+ hematopoietic cells. Aberrant splicing was associated with the usage of cryptic 3' splice and branchpoint sites, as described for human SF3B1 mutants. However, we found a little overlap between aberrantly spliced mRNAs in mouse versus human, suggesting that anemia may be a consequence of globally disrupted splicing. Furthermore, the murine orthologues of genes associated with ring sideroblasts in human MDS, including Abcb7 and Tmem14c, were not aberrantly spliced in Sf3b1K700E/+ mice. Our findings demonstrate that, despite significant differences in affected transcripts, there is overlap in the phenotypes associated with SF3B1-K700E between human and mouse. Future studies should focus on understanding the basis of these similarities and differences as a means of deciphering the consequences of spliceosome gene mutations in MDS.
Insights
Mutations in the spliceosome gene SF3B1 cause myelodysplastic syndromes (MDS). Mouse models show anemia and impaired blood cell formation, despite differences in specific gene splicing compared to human MDS.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Heterozygous somatic mutations in the spliceosome gene SF3B1 are implicated in age-related clonal hematopoiesis and myelodysplastic syndromes (MDS).
- The SF3B1-K700E mutation is the most common SF3B1 variant observed in MDS patients.
Purpose of the Study:
- To investigate the role of the common SF3B1-K700E mutation in hematopoietic disorders.
- To generate and characterize a mouse model expressing hematopoietic-specific Sf3b1-K700E.
Main Methods:
- Generation of knock-in mice with hematopoietic-specific Sf3b1-K700E expression.
- Phenotypic analysis of Sf3b1K700E/+ mice, including erythropoiesis and hematopoietic stem cell function.
- Global RNA splicing analysis in Sf3b1K700E/+ hematopoietic cells.
Main Results:
- Sf3b1K700E/+ mice exhibited impaired erythropoiesis, progressive anemia, reduced hematopoietic stem cell numbers, and decreased host-repopulating fitness.
- Aberrant RNA splicing, including cryptic splice site usage, was observed in Sf3b1K700E/+ hematopoietic cells, consistent with human SF3B1 mutants.
- Limited overlap in aberrantly spliced transcripts was found between mouse and human SF3B1 mutants, suggesting anemia results from globally disrupted splicing.
- Murine orthologues of human MDS-associated ring sideroblast genes (e.g., Abcb7, Tmem14c) were not aberrantly spliced in the mouse model.
Conclusions:
- Despite differences in specific RNA splicing patterns, the SF3B1-K700E mutation induces overlapping phenotypic consequences in mouse and human MDS models.
- Anemia in this model appears to be a result of globally disrupted RNA splicing rather than specific gene dysregulation.
- Further research is needed to elucidate the similarities and differences in spliceosome gene mutation consequences between species.
Related Concept Videos
02:18Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
01:01Regulation of Hematopoietic Stem Cells